Q32 Bio (QTTB) Other Accumulated Expenses (2017 - 2023)

Q32 Bio's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $205000.0 for Q3 2023.

• In Q3 2023, Other Accumulated Expenses fell 59.41% year-over-year to $205000.0; the TTM figure through Sep 2023 stood at $205000.0 (down 59.41% YoY), while the FY2022 annual figure was $2.3 million, up 3.19% from the prior year.
• Other Accumulated Expenses was $205000.0 for Q3 2023 at Q32 Bio, down from $12.6 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $12.6 million in Q2 2023 to a low of $204000.0 in Q4 2020.
• Historically, Other Accumulated Expenses has averaged $2.6 million across 5 years, with a median of $1.4 million in 2019.
• Biggest YoY gain for Other Accumulated Expenses was 975.0% in 2021; the steepest drop was 88.68% in 2021.
• A 5-year view of Other Accumulated Expenses shows it stood at $256000.0 in 2019, then decreased by 20.31% to $204000.0 in 2020, then surged by 975.0% to $2.2 million in 2021, then climbed by 3.19% to $2.3 million in 2022, then slumped by 90.94% to $205000.0 in 2023.
• The last three Other Accumulated Expenses figures came in at $205000.0 (Q3 2023), $12.6 million (Q2 2023), and $9.2 million (Q1 2023), per Business Quant data.